Drug containing patch for intraepidermal delivery
The P.L.E.A.S.E.® - platform has been developed in a way that makes it compatible with most conventional transdermal patch systems and other transdermal systems.
Pantec Biosolutions' patch strategy
- The P.L.E.A.S.E.® - platform is independent of current or future patch designs
- Pantec Biosolutions has established a team of scientists that carry out preclinical R&D with target drugs. Major tasks involve formulation development and in vitro permeation studies on human skin. The team also works with drug formulations that have been developed by our Pharma partner companies.
- Pantec Biosolutions strategy is to work with reputable transdermal drug delivery companies that have a proven track record with regard to commercialised drug patches.
- Several relationships with such transdermal drug delivery companies are well established and Pantec Biosolutions will partner with one or several of them to bring the combination product P.L.E.A.S.E.® - device and transdermal drug patch to the market.
|
|
| 
